TRILINK BIOTECHNOLOGIES has a total of 19 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and organic fine chemistry are RAVGEN INC, WINGER EDWARD E and BIOTRONICS CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 | |
#6 | United Kingdom | 1 | |
#7 | Hong Kong | 1 | |
#8 | Mexico | 1 | |
#9 | New Zealand | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Lebedev Alexandre | 13 |
#2 | Zon Gerald | 11 |
#3 | Koukhareva Inna | 7 |
#4 | Paul Natasha | 6 |
#5 | Lebedev Alexandre V | 6 |
#6 | Shum Jonathan | 6 |
#7 | Inna Koukhareva | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012094343A1 | Chemically substituted thermosensitive probes and cofactors for hot start ligation | |
WO2011005762A1 | Chemically modified ligase cofactors, donors and acceptors | |
CN102105481A | Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid | |
AU2007268075A1 | Chemically modified oligonucleotide primers for nucleic acid amplification |